A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 1,103 shares of VRTX stock, worth $554,202. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,103
Previous 1,102 0.09%
Holding current value
$554,202
Previous $460,000 12.17%
% of portfolio
0.07%
Previous 0.07%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $392 - $485
1 Added 0.09%
1,103 $516,000
Q1 2024

May 09, 2024

SELL
$407.69 - $446.08 $407 - $446
-1 Reduced 0.09%
1,102 $460,000
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $343 - $410
-1 Reduced 0.09%
1,103 $448,000
Q3 2023

Nov 07, 2023

SELL
$338.18 - $362.46 $3,043 - $3,262
-9 Reduced 0.81%
1,104 $383,000
Q2 2023

Aug 07, 2023

SELL
$314.42 - $351.91 $314 - $351
-1 Reduced 0.09%
1,113 $391,000
Q1 2023

May 03, 2023

BUY
$283.23 - $323.1 $3,398 - $3,877
12 Added 1.09%
1,114 $350,000
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $33,148 - $37,291
-116 Reduced 9.52%
1,102 $318,000
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $4,655 - $5,194
-17 Reduced 1.38%
1,218 $353,000
Q2 2022

Aug 03, 2022

BUY
$234.96 - $292.55 $60,619 - $75,477
258 Added 26.41%
1,235 $348,000
Q1 2022

Apr 20, 2022

SELL
$221.42 - $260.97 $9,299 - $10,960
-42 Reduced 4.12%
977 $255,000
Q4 2021

Jan 21, 2022

BUY
$177.01 - $223.45 $180,373 - $227,695
1,019 New
1,019 $224,000
Q2 2021

Aug 02, 2021

SELL
$187.49 - $221.1 $204,364 - $240,999
-1,090 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$207.02 - $241.31 $28,361 - $33,059
137 Added 14.38%
1,090 $235,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $3,312 - $4,417
16 Added 1.71%
953 $225,000
Q3 2020

Nov 03, 2020

SELL
$255.65 - $303.1 $1,789 - $2,121
-7 Reduced 0.74%
937 $255,000
Q2 2020

Jul 27, 2020

SELL
$225.48 - $295.8 $15,558 - $20,410
-69 Reduced 6.81%
944 $274,000
Q1 2020

May 11, 2020

BUY
$199.77 - $247.81 $202,367 - $251,031
1,013 New
1,013 $240,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pinnacle Wealth Planning Services, Inc. Portfolio

Follow Pinnacle Wealth Planning Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.